| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. | Cancer Res | 2008 | 2.29 |
| 2 | Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. | Proc Natl Acad Sci U S A | 2006 | 1.61 |
| 3 | Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. | Prostate | 2003 | 1.60 |
| 4 | Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. | Sci Transl Med | 2012 | 1.29 |
| 5 | Benzoylphenylurea sulfur analogues with potent antitumor activity. | J Med Chem | 2006 | 0.89 |
| 6 | Nonimmunosuppressant immunophilin ligand GPI-1046 does not promote in vitro growth of prostate cancer cells. | Urology | 2005 | 0.80 |
| 7 | Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate. | Prostate | 2014 | 0.75 |